On Scene ECPR in Ostrava
The Effectiveness of ECPR on the Scene and in Hospital for Out-of-hospital Cardi-ac Arrest (OHCA) in the Moravian-Silesian Region.
1 other identifier
interventional
90
1 country
2
Brief Summary
On-scene extracorporeal pulmonary resuscitation (ECPR) for out-of-hospital cardiac arrest (OHCA) seems to speed up the start of extracorporeal membrane oxygenation (ECMO) and shorten low flow during cardiopulmonary resuscitation (CPR) in case of refractory cardiac arrest. The primary goal is to verify the benefit of on-scene ECPR in terms of shortening the collapse-to-ECMO interval. The secondary goal is to compare outcomes in the on-scene ECPR group with hospital cannulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2026
CompletedFirst Posted
Study publicly available on registry
January 28, 2026
CompletedStudy Start
First participant enrolled
January 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
January 30, 2026
January 1, 2026
2.9 years
January 9, 2026
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Hospital survival
Hospital survival will be assessed 30 days after the cardiac arrest
30 days after the cardiac arrest
ICU stay
The length of the Intensive Care Unit (ICU) stay will be assessed in days.
Through the ICU stay, on average 12 days
Neurologic outcomes
Neurologic outcomes will be assessed in patients using the Cerebral Performance Category (CPC) score. The CPC score is a 1-to-5 scale assessing neurological outcome, most commonly after cardiac arrest, where 1 is best (normal brain function) and 5 is worst (brain death).
30 days after the cardiac arrest
Secondary Outcomes (4)
Collapse to ECMO interval
One hour
Collapse to ECMO interval
From the collapse (cardiac arrest) to ECMO initiation
Long-term outcome - Survival
6 months after the collapse
Long-term outcome - Quality of Life
6 months after the collapse
Study Arms (2)
ECPR on scene
EXPERIMENTALOn-scene ECPR cannulation by mobile ECMO team according to protocol if the location of the arrest and circumstances appear to be suitable (distance from the ECMO centre, transport logistics, in an ambulance/at home, etc.)
ECPR in hospital
ACTIVE COMPARATORHospital ECPR cannulation at Emergency Department by ECMO team accord-ing to protocol if a on scene ECPR call-out was not indicated.
Interventions
ECPR (Extracorporeal Cardiopulmonary Resuscitation) is a critical, advanced resuscitation technique using Veno-arterial Extracorporeal Membrane Oxygenation for patients in cardiac arrest where conventional CPR fails, functioning as a bridge to restore circulation and oxygenation by pumping and oxygenating blood outside the body before returning it.
ECPR (Extracorporeal Cardiopulmonary Resuscitation) is a critical, advanced resuscitation technique using Veno-arterial Extracorporeal Membrane Oxygenation for patients in cardiac arrest where conventional CPR fails, functioning as a bridge to restore circulation and oxygenation by pumping and oxygenating blood outside the body before returning it.
Eligibility Criteria
You may qualify if:
- Presumed cardiac aetiology of the cardiac arrest
- Witnessed collapse
- Bystander CPR
- Estimated age ≤ 70 years
- Body weight ≥15 Kg
You may not qualify if:
- Known terminal malignant disease
- Known terminal chronic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Emergency Medical Services, Moravian-Silesian Region
Ostrava, Moravian-Silesian Region, 700 30, Czechia
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, 708 52, Czechia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Filip Burša, MD, PhD, EDEC
University Hospital Ostrava
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking will be used in the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2026
First Posted
January 28, 2026
Study Start
January 30, 2026
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2029
Last Updated
January 30, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available to other researchers. The data may be provided upon reasonable request.